Article: Migraine Sufferers not Finding Relief From Over-The-Counter Pain Relievers Now Have an Effective Option; Study Published in Headache Finds Patients Who Responded Poorly to Excedrin-Migraine(R) Get Significant Pain Relief With Relpax(R) (eletriptan).

Despite advances in the treatment of migraine, the majority of sufferers (57 percent) continue to self-medicate with over-the-counter (OTC) pain relievers, which, according to medical guidelines, are not the most effective treatment choice for many patients with moderate to severe migraine pain. Now, according to a study published this month in the journal Headache, patients not finding relief with Excedrin-Migraine(R), a commonly used OTC treatment, have an effective option.

The first published study of its kind found that 81 percent of migraine sufferers who did not respond well to Excedrin-Migraine experienced significant headache relief (mild or no pain) two ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!